• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Ahmedabad , Nov. 3

The Mehsana-based Hester Pharmaceuticals Ltd's net profit for the second quarter ended September 30 was at Rs 1.37 crore (Rs 1.07 crore), an increase of 28 per cent, according to the company.

Negotiations are on with international companies for manufacturing animal vaccines for their international markets even as the company is expanding its capacity.

Hester has reported a turnover of Rs 5.57 crore in the second quarter (Rs 4.04 crore), registering an increase in sales by 38 per cent, its CEO and Managing Director, Mr Rajiv Gandhi, said in a release here.

The company completed its rights issue and allotted 14,83,200 shares in August, at Rs 70 per share.

The enhanced equity capital now stood at Rs 5.19 crore as against Rs 3.71 crore as on June 30 this year.

EPI has been registered at Rs 3.11 for the second quarter (on the effective paid-up capital — post preferential and rights allotment).

More Stories on : Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Sadbhav Engg Q2 net at Rs 2.6 cr

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line